SERIAL #79355200
LIVE
Serial Number
79355200
Owner
DENCARE(CHONGQING) ORAL CARE CO., LTD.Attorney
Nazly Aileen BayramogluFiling Date
Sep 5, 2022
Serial #79355200 Trademark
Serial Number: 79355200 • Registration: 7102595
Serial #79355200 is a trademark filed by
DENCARE(CHONGQING) ORAL CARE CO., LTD.
on September 5, 2022. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 21 (Housewares).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Nazly Aileen Bayramoglu Bayramoglu Law Offices LLC
1540 West Warm Springs Road Suite 100
Henderson
NV 89014
United States
Trademark Details
Filing Date
September 5, 2022
Registration Date
July 11, 2023
Published for Opposition
April 25, 2023
Filing History
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 6, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 12, 2023 FICS
FINAL DISPOSITION PROCESSED
Oct 12, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 11, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 11, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 11, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2023 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 23, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2023 TROA
REFUSAL PROCESSED BY IB
Mar 7, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 16, 2023 RFCS
REFUSAL PROCESSED BY MPU
Feb 16, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 21, 2022 RFCR
NON-FINAL ACTION WRITTEN
Dec 20, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 29, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 23, 2022 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 22, 2022 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 17, 2022 REPR
